Callan Capital, LLC - IMMUNOCELLULAR THERAPEUTICS ownership

Quarter-by-quarter ownership
Callan Capital, LLC ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q2 2015$143,000
-8.9%
303,912
-6.2%
0.03%
-9.1%
Q1 2015$157,000
-45.5%
323,912
-17.8%
0.03%
-49.2%
Q4 2014$288,000
-17.9%
393,9120.0%0.06%
-33.0%
Q3 2014$351,000
-20.4%
393,9120.0%0.10%
-17.8%
Q2 2014$441,000
+418.8%
393,912
+462.7%
0.12%
+321.4%
Q1 2014$85,000
+30.8%
70,0000.0%0.03%
+12.0%
Q4 2013$65,000
-63.9%
70,0000.0%0.02%
-70.9%
Q3 2013$180,000
+2.3%
70,000
-23.0%
0.09%
-14.0%
Q2 2013$176,00090,9090.10%
Other shareholders

There were no reported owners of IMMUNOCELLULAR THERAPEUTICS in Q3 2023.

NameSharesValueWeighting ↓
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders